As Abbvie (ABBV) Shares Declined, Jupiter Asset Management LTD Trimmed Its Stake; Sheets Smith Wealth Management Has Upped Unitedhealth Group (UNH) Stake by $421,527

June 16, 2018 - By Clifton Ray

AbbVie Inc. (NYSE:ABBV) Logo

Sheets Smith Wealth Management increased its stake in Unitedhealth Group Inc (UNH) by 26.91% based on its latest 2018Q1 regulatory filing with the SEC. Sheets Smith Wealth Management bought 1,979 shares as the company’s stock rose 4.65% while stock markets declined. The institutional investor held 9,333 shares of the medical specialities company at the end of 2018Q1, valued at $2.00 million, up from 7,354 at the end of the previous reported quarter. Sheets Smith Wealth Management who had been investing in Unitedhealth Group Inc for a number of months, seems to be bullish on the $245.99 billion market cap company. The stock increased 0.61% or $1.55 during the last trading session, reaching $255.98. About 4.77 million shares traded or 48.99% up from the average. UnitedHealth Group Incorporated (NYSE:UNH) has risen 37.57% since June 16, 2017 and is uptrending. It has outperformed by 25.00% the S&P500. Some Historical UNH News: 17/04/2018 – The 4 major averages all closed sharply higher Tuesday, as investor sentiment was boosted by strong results from Netflix and UnitedHealth; 06/03/2018 – UNITEDHEALTH TO GIVE PRESCRIPTION DRUG DISCOUNTS TO MEMBERS; 06/03/2018 – MEDIA-UnitedHealth joins bids for Envision unit – Bloomberg; 17/04/2018 – Health insurer UnitedHealth’s quarterly profit rises 30.6 pct; 16/05/2018 – United Healthcare Steve Nelson To Keynote Second Annual Medicare Advantage Summit; 16/04/2018 – UnitedHealth Group Inc expected to post earnings of $2.90 a share – Earnings Preview; 28/03/2018 – Cramer also sits down with the CEOs of UnitedHealth, PVH and Norwegian Cruise Line Holdings; 03/05/2018 – Construction Begins for The Elisabetta, a New Community That Will Bring High-Quality, Affordable Housing to the Globeville Neighborhood of Denver; 20/04/2018 – UnitedHealth: Wichmann Succeeded Hemsley as Chief Executive Officer; 13/03/2018 – UnitedHealth Names Larry Renfro to Lead Enterprise Growth Efforts and Optum’s Next-Generation Investment Initiatives Through an Expanded Optum Ventures

Jupiter Asset Management Ltd decreased its stake in Abbvie Inc (ABBV) by 26.68% based on its latest 2018Q1 regulatory filing with the SEC. Jupiter Asset Management Ltd sold 143,090 shares as the company’s stock declined 16.83% with the market. The institutional investor held 393,244 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $37.22 million, down from 536,334 at the end of the previous reported quarter. Jupiter Asset Management Ltd who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $150.76B market cap company. The stock increased 0.83% or $0.82 during the last trading session, reaching $99.57. About 20.81 million shares traded or 126.54% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 52.41% since June 16, 2017 and is uptrending. It has outperformed by 39.84% the S&P500. Some Historical ABBV News: 22/03/2018 – AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T) for Third-Line Treatment of Patients wi; 05/04/2018 – BIOGEN: PRECISE TERMS OF PACT WITH ABBVIE ARE CONFIDENTIAL; 23/05/2018 – MERCK & CO INC – SAFETY PROFILE OF KEYTRUDA IN COMBINATION WAS CONSISTENT WITH THAT PREVIOUSLY OBSERVED IN LUNG CANCER; 21/05/2018 – LANNETT COMPANY INC – FDA APPROVAL FOR DRONABINOL CAPSULES,THERAPEUTIC EQUIVALENT TO REFERENCE LISTED DRUG, MARINOL CAPSULES OF ABBVIE; 22/03/2018 – AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T) for Third-Line Treatment of Patients with DLL3-Expressing Relapsed/Refractory Small Cell Lung Cancer; 24/05/2018 – AbbVie: IMBRUVICA Plus GAZYVA Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia Patients Met Primary Endpoint; 11/04/2018 – MYLAN, BIOCON SEEK TO ACCELERATE INTRODUCTION OF ADALIMUMAB BIOSIMILAR IN EU; 01/05/2018 – AbbVie Submits Marketing Authorization Application to the European Medicines Agency for Investigational Treatment Risankizumab; 26/04/2018 – ABBVIE INC – IN 2018, WILL EXPERIENCE ONE-TIME NET TAX BENEFIT RELATED TO TIMING OF PHASE IN OF PROVISIONS OF NEW LEGISLATION ON CERTAIN SUBSIDIARIES; 12/03/2018 – AstraZeneca Says Phase 3 Trial Results for Imfinzi Antibody Delayed

Since December 18, 2017, it had 0 buys, and 9 selling transactions for $25.06 million activity. RICHMOND TIMOTHY J. sold 87,040 shares worth $8.57 million. 83,574 shares were sold by ALBAN CARLOS, worth $9.57M. The insider GONZALEZ RICHARD A sold 8,280 shares worth $976,084. $311,684 worth of stock was sold by SEVERINO MICHAEL on Wednesday, February 28. CHASE WILLIAM J sold $8.31 million worth of stock. Michael Robert A. sold $119,351 worth of stock or 992 shares.

Investors sentiment decreased to 0.7 in Q1 2018. Its down 0.10, from 0.8 in 2017Q4. It worsened, as 61 investors sold ABBV shares while 737 reduced holdings. 127 funds opened positions while 428 raised stakes. 1.06 billion shares or 0.67% less from 1.06 billion shares in 2017Q4 were reported. Alpine Woods Capital Limited owns 34,783 shares for 0.17% of their portfolio. Meag Munich Ergo Kapitalanlagegesellschaft Mbh has invested 0.79% of its portfolio in AbbVie Inc. (NYSE:ABBV). Segment Wealth Management Llc has 8,338 shares for 0.2% of their portfolio. Bnp Paribas Asset Mngmt Holdings Sa reported 196,952 shares. Founders Mgmt Ltd Llc has 1.07% invested in AbbVie Inc. (NYSE:ABBV) for 25,502 shares. Atlas Browninc holds 30,592 shares or 0.53% of its portfolio. Advisory Research Inc reported 140,690 shares. Cognios Cap Ltd Liability Corporation has invested 0.08% of its portfolio in AbbVie Inc. (NYSE:ABBV). Eaton Vance Management reported 0.81% of its portfolio in AbbVie Inc. (NYSE:ABBV). South Texas Money Ltd invested in 16,590 shares. Apriem Advisors reported 67,238 shares stake. 4,256 were reported by Heritage Wealth Advisors. Norinchukin State Bank The accumulated 0.36% or 228,085 shares. Nelson Van Denburg Campbell Wealth Mngmt Gp Limited Liability Co has 23,596 shares for 0.51% of their portfolio. Transamerica Fincl Advsrs reported 0.08% in AbbVie Inc. (NYSE:ABBV).

Among 24 analysts covering Abbvie Inc (NYSE:ABBV), 9 have Buy rating, 3 Sell and 12 Hold. Therefore 38% are positive. Abbvie Inc had 96 analyst reports since July 21, 2015 according to SRatingsIntel. As per Monday, April 30, the company rating was maintained by Morgan Stanley. The rating was maintained by Credit Suisse with “Hold” on Wednesday, June 7. The firm has “Hold” rating by Bank of America given on Monday, March 26. The stock has “Buy” rating by Jefferies on Friday, March 23. The rating was maintained by Jefferies on Friday, April 13 with “Buy”. The firm has “Buy” rating by Cowen & Co given on Friday, January 26. BMO Capital Markets maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, April 28. BMO Capital Markets has “Hold” rating and $63 target. The rating was maintained by Cowen & Co with “Hold” on Friday, July 28. The stock of AbbVie Inc. (NYSE:ABBV) has “Equal-Weight” rating given on Tuesday, December 1 by Barclays Capital. The firm has “Market Perform” rating by Cowen & Co given on Monday, June 6.

Jupiter Asset Management Ltd, which manages about $3.29B US Long portfolio, upped its stake in Regal Beloit Corp (NYSE:RBC) by 7,287 shares to 227,882 shares, valued at $16.72M in 2018Q1, according to the filing. It also increased its holding in United Nat Foods Inc (NASDAQ:UNFI) by 10,284 shares in the quarter, for a total of 326,732 shares, and has risen its stake in Citizens Finl Group Inc (NYSE:CFG).

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 earnings per share, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $2.98 billion for 12.64 P/E if the $1.97 EPS becomes a reality. After $1.87 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “More Thoughts On AbbVie’s Rova-T Implosion” on June 06, 2018, also Fool.com with their article: “Is AbbVie Inc. (ABBV) a Buy?” published on May 30, 2018, Fool.com published: “3 Reasons to Expect Smooth Sailing for AbbVie’s Mission-Critical Candidate” on June 10, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Benzinga.com and their article: “Benzinga’s Bulls & Bears Of The Week: AbbVie, Lululemon, Netflix, Snap And More” published on June 03, 2018 as well as Seekingalpha.com‘s news article titled: “AbbVie: Growth And Dividend In One Package” with publication date: June 15, 2018.

More notable recent UnitedHealth Group Incorporated (NYSE:UNH) news were published by: Seekingalpha.com which released: “UnitedHealth, Quest Diagnostics unveil strategic partnership” on May 24, 2018, also Globenewswire.com with their article: “Market Trends Toward New Normal in Cheniere Energy Partners, LP, UnitedHealth Group, Anthem, Sage Therapeutics …” published on June 12, 2018, Bizjournals.com published: “Polaris, Securian join ranks of Fortune 500 companies; UnitedHealth moves into Top 5 (slideshow)” on May 21, 2018. More interesting news about UnitedHealth Group Incorporated (NYSE:UNH) were released by: Seekingalpha.com and their article: “The Bulls Are Listening – Cramer’s Mad Money (6/6/18)” published on June 07, 2018 as well as Schaeffersresearch.com‘s news article titled: “Best Dow Stock to Own Next Week” with publication date: May 25, 2018.

Sheets Smith Wealth Management, which manages about $700.54 million and $416.18M US Long portfolio, decreased its stake in Carnival Corp (NYSE:CCL) by 7,195 shares to 7,323 shares, valued at $480,000 in 2018Q1, according to the filing. It also reduced its holding in Conocophillips (NYSE:COP) by 11,381 shares in the quarter, leaving it with 10,625 shares, and cut its stake in Avery Dennison Corp (NYSE:AVY).

Investors sentiment is 0.96 in Q1 2018. Its the same as in 2017Q4. It has no change, as 55 investors sold UNH shares while 532 reduced holdings. only 125 funds opened positions while 440 raised stakes. 789.19 million shares or 2.09% less from 806.07 million shares in 2017Q4 were reported. City has invested 0.02% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). 10.15M are owned by Geode Cap Management Ltd. Glenview Comml Bank Tru Dept owns 0.22% invested in UnitedHealth Group Incorporated (NYSE:UNH) for 2,176 shares. Davis Selected Advisers holds 55,035 shares or 0.05% of its portfolio. Great Lakes Advisors Lc holds 1.79% or 384,907 shares. Asset holds 6,500 shares. 19,033 are owned by Martin Currie Ltd. Rafferty Asset Management stated it has 0.01% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). Commerce Commercial Bank owns 170,397 shares or 0.48% of their US portfolio. Thompson Siegel & Walmsley Limited Liability reported 2,036 shares. 1,186 are held by Ledyard National Bank & Trust. Exxonmobil Inv Management Tx, a Texas-based fund reported 148,139 shares. Ssi Invest, a California-based fund reported 4,067 shares. 1,733 are owned by Gradient Invests Limited Liability Company. Eubel Brady & Suttman Asset Mgmt owns 1,034 shares.

UnitedHealth Group Incorporated (NYSE:UNH) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>